Read this company snapshot
Daily valuation snapshot
Humacyte, Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.41
- Market capitalization (USD)
- $112,591,571.96
- Price / earnings (TTM)
- Not reported
- Price / book
- 3.6
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research HUMA in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research HUMA in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing HUMA with another company.
| Daily close (USD) | $0.41 |
| Market capitalization (USD) | $112,591,571.96 |
| Price / earnings (TTM) | Not reported |
| Price / book | 3.6 |
No matching rows. Clear the filter to see all records.
Read HUMA's valuation metrics
Company size
Humacyte, Inc. Common Stock's recorded market capitalization is $112,591,571.96. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
HUMA's recorded price-to-book ratio is 3.6. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Humacyte, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about HUMA. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow HUMA's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.